Shire sues Teva over generic Adderall

03/4/2006 | Red Herring

Shire subsidiary Shire Laboratories filed suit in the U.S. against Teva Pharmaceutical Industries, claiming Teva's plan to sell a generic version of the attention deficit hyperactivity disorder drug Adderall XR infringes on Shire's patent. The drug, which is Shire's major product, accounted for 26% of the ADHD market last year.

View Full Article in:

Red Herring

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC